Results 161 to 170 of about 16,345 (198)

A peripheral carboxysome component regulates cyanobacterial glycogen deposition. [PDF]

Proc Natl Acad Sci U S A
MacCready JS, Boren DM, Santos-Merino M, Sharpe LA, Lechno-Yossef S, Vermaas JV, Ducat DC.   +6 more
europepmc   +1 more source

A probiotic shield: Lactobacillus acidophilus immobilized in bacterial cellulose for a more sustainable release process and improved viability. [PDF]

J Sci Food Agric
Eshkafti PM, Rahaiee S, Gholami D.
europepmc   +1 more source

Unveiling genetic diversity and population structure in jackfruit (Artocarpus heterophyllus) through SNP markers for enhanced breeding and conservation. [PDF]

BMC Plant Biol
Amin N, Chaudhary R, Wang Z, Islam A, Ali J, Islam T, Sharpe AG.   +6 more
europepmc   +1 more source

Complete genome sequence of <i>Lactobacillus acidophilus</i> LA120 from the NORDBIOTIC collection. [PDF]

Microbiol Resour Announc
Szczepankowska A, Cukrowska B, Aleksandrzak-Piekarczyk T.   +2 more
europepmc   +1 more source

Equity premium forecasting with reliability-screened forward-looking signals. [PDF]

PLoS One
Huh J, Jeon J, Jeong S.
europepmc   +1 more source

Cost-effectiveness of a community-based dementia support model: evidence from a real-world economic evaluation. [PDF]

Cost Eff Resour Alloc
King RL, Warren S, Vass E, Sharpe BT, Beaumont K, Seymour S, Bell S, Pacella R, Pereira A.   +8 more
europepmc   +1 more source

Deep momentum networks with market trend dynamics. [PDF]

PLoS One
Song J, Jeon J.
europepmc   +1 more source

Design of INFORMUS, a pragmatic, randomized, double-blind, placebo-controlled study of cardiovascular outcomes with the extended-release, fixed-dose combination of naltrexone and bupropion. [PDF]

Obes Pillars
Kyle M, Savastano DM, Sharpe TA, Kelly B.   +3 more
europepmc   +1 more source

An Entropy-Regularised AI Framework for Multi-Asset Volatility Spillover Forecasting and CVaR-Constrained Portfolio Allocation in Financial Markets. [PDF]

Entropy (Basel)
Yu J, Wang L, Sun X.
europepmc   +1 more source

Saruparib in combination with androgen receptor pathway inhibitors in metastatic hormone-sensitive prostate cancer: EvoPAR-Prostate01. [PDF]

Future Oncol
Azad AA, Agarwal N, Armstrong AJ, Hellmis E, Sugimoto M, Ürün Y, Xing N, Aregay M, Lima J, Meulendijks D, Chi KN.   +10 more
europepmc   +1 more source